Mutations of the H-Ras proto-oncogene increase phosphatase 2A activity and sensitize cancer cells to okadaic acid-induced apoptosis [15], the effects of cis-UCA might not be linked to these mutations, as the H-Ras mutation seems to be rather rare in bladder cancer [16]. The gene discussed is HRAS; the disease is urinary bladder cancer.